<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03878576</url>
  </required_header>
  <id_info>
    <org_study_id>KME/0120-441/2018/4</org_study_id>
    <nct_id>NCT03878576</nct_id>
  </id_info>
  <brief_title>The Effect of Content of Barley Beta-glucans in Bread on Postprandial Blood Sugar</brief_title>
  <acronym>ARRS-bGL-01</acronym>
  <official_title>The Effect of Content of Barley Beta-glucans in Bread on Postprandial Blood Sugar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutrition Institute, Slovenia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zdravstveni dom Ljubljana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Slovenian Research Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Valens Int. d.o.o., Slovenija</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nutrition Institute, Slovenia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of content of barley beta-glucans in bread on postprandial blood sugar will be
      measured with open-label crossover study. Study will be conducted in Slovenia on 10-12 adult
      subjects who will test three barley beta-glucan containing bread formulations (food) in
      comparison with a reference white bread. Objective of the study is to investigate the
      influence of the content of barley beta-glucan in bread on glycaemic index (incremental area
      under the curve (IAUC) for the blood glucose response curve for barley beta-glucan containing
      breads in comparison to reference white bread.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Actual">December 7, 2018</completion_date>
  <primary_completion_date type="Actual">December 7, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in glycaemic response (capillary blood glucose)</measure>
    <time_frame>2 hours</time_frame>
    <description>Change in incremental area under the curve (IAUC) the blood glucose response curve for barley beta-glucan containing breads (investigational products; IP1-3), in comparison to white bread (reference product; RP)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Glucose level as measured with continuous glucose monitor (CGM)</measure>
    <time_frame>up to 3 hours</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Glycemic Index</condition>
  <arm_group>
    <arm_group_label>REFERENCE: white bread - BGL0 [RP]</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants consume a meal of bread BGL0 standardised to contain 25 g of available carbohydrates. Sample consumed together with 300 mL of water in up to 15 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEST: b-glucan enriched bread - BGL2 [IP1]</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants consume a meal of bread BGL2 standardised to contain 25 g of available carbohydrates. Sample consumed together with 300 mL of water in up to 15 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEST: b-glucan enriched bread - BGL3 [IP2]</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants consume a meal of bread BGL3 standardised to contain 25 g of available carbohydrates. Sample consumed together with 300 mL of water in up to 15 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEST: b-glucan enriched bread - BGL4 [IP3]</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants consume a meal of bread BGL4 standardised to contain 25 g of available carbohydrates. Sample consumed together with 300 mL of water in up to 15 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>REFERENCE: white bread - BGL0 [RP]</intervention_name>
    <description>Determination of glycemic response after consumption of BGL0.</description>
    <arm_group_label>REFERENCE: white bread - BGL0 [RP]</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEST: b-glucan enriched bread - BGL2 [IP1]</intervention_name>
    <description>Determination of glycemic response after consumption of BGL0.</description>
    <arm_group_label>TEST: b-glucan enriched bread - BGL2 [IP1]</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEST: b-glucan enriched bread - BGL3 [IP2]</intervention_name>
    <description>Determination of glycemic response after consumption of BGL0.</description>
    <arm_group_label>TEST: b-glucan enriched bread - BGL3 [IP2]</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEST: b-glucan enriched bread - BGL4 [IP3]</intervention_name>
    <description>Determination of glycemic response after consumption of BGL0.</description>
    <arm_group_label>TEST: b-glucan enriched bread - BGL4 [IP3]</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject Informed consent form (ICF) is singed

          -  Aged above 18 years at the time of the signature of ICF

          -  No known food allergy or intolerance

          -  No medications known to affect glucose tolerance — stable doses of oral
             contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or
             drugs to treat hypertension or osteoporosis are acceptable.

          -  Willing to follow all study procedures, including attending all site visits (including
             sessions for blood sampling and use of CGM)

          -  Body mass index (BMI) &gt; 25

        Exclusion Criteria:

          -  Subject Informed consent form (ICF) is singed

          -  Aged above 18 years at the time of the signature of ICF

          -  No known food allergy or intolerance

          -  No medications known to affect glucose tolerance — stable doses of oral
             contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or
             drugs to treat hypertension or osteoporosis are acceptable.

          -  Willing to follow all study procedures, including attending all site visits (including
             sessions for blood sampling and use of CGM)

          -  Body mass index (BMI) &gt; 25
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Igor Pravst, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut za nutricionistiko</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nutrition Institite</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 14, 2019</study_first_submitted>
  <study_first_submitted_qc>March 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2019</study_first_posted>
  <last_update_submitted>March 15, 2019</last_update_submitted>
  <last_update_submitted_qc>March 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycemic Index</keyword>
  <keyword>glycemic response</keyword>
  <keyword>bread</keyword>
  <keyword>barley</keyword>
  <keyword>beta-glucans</keyword>
  <keyword>glucose level</keyword>
  <keyword>continous glucose monitoring</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

